These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 9811457

  • 1. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells.
    Suzuki R, Sakamoto H, Yasukawa H, Masuhara M, Wakioka T, Sasaki A, Yuge K, Komiya S, Inoue A, Yoshimura A.
    Oncogene; 1998 Oct 29; 17(17):2271-8. PubMed ID: 9811457
    [Abstract] [Full Text] [Related]

  • 2. Suppressor of cytokine signaling 1/JAB and suppressor of cytokine signaling 3/cytokine-inducible SH2 containing protein 3 negatively regulate the signal transducers and activators of transcription signaling pathway in normal human epidermal keratinocytes.
    Yamasaki K, Hanakawa Y, Tokumaru S, Shirakata Y, Sayama K, Hanada T, Yoshimura A, Hashimoto K.
    J Invest Dermatol; 2003 Apr 29; 120(4):571-80. PubMed ID: 12648219
    [Abstract] [Full Text] [Related]

  • 3. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T, Senga T, Naito Y, Matsuda S, Miyake Y, Yoshimura A, Hamaguchi M.
    Oncogene; 2000 Sep 28; 19(41):4795-801. PubMed ID: 11032030
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation.
    Cassatella MA, Gasperini S, Bovolenta C, Calzetti F, Vollebregt M, Scapini P, Marchi M, Suzuki R, Suzuki A, Yoshimura A.
    Blood; 1999 Oct 15; 94(8):2880-9. PubMed ID: 10515892
    [Abstract] [Full Text] [Related]

  • 5. Cloning and characterization of novel CIS family genes.
    Masuhara M, Sakamoto H, Matsumoto A, Suzuki R, Yasukawa H, Mitsui K, Wakioka T, Tanimura S, Sasaki A, Misawa H, Yokouchi M, Ohtsubo M, Yoshimura A.
    Biochem Biophys Res Commun; 1997 Oct 20; 239(2):439-46. PubMed ID: 9344848
    [Abstract] [Full Text] [Related]

  • 6. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain.
    Sasaki A, Yasukawa H, Suzuki A, Kamizono S, Syoda T, Kinjyo I, Sasaki M, Johnston JA, Yoshimura A.
    Genes Cells; 1999 Jun 20; 4(6):339-51. PubMed ID: 10421843
    [Abstract] [Full Text] [Related]

  • 7. A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons.
    Sakamoto H, Yasukawa H, Masuhara M, Tanimura S, Sasaki A, Yuge K, Ohtsubo M, Ohtsuka A, Fujita T, Ohta T, Furukawa Y, Iwase S, Yamada H, Yoshimura A.
    Blood; 1998 Sep 01; 92(5):1668-76. PubMed ID: 9716595
    [Abstract] [Full Text] [Related]

  • 8. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo.
    Hamanaka I, Saito Y, Yasukawa H, Kishimoto I, Kuwahara K, Miyamoto Y, Harada M, Ogawa E, Kajiyama N, Takahashi N, Izumi T, Kawakami R, Masuda I, Yoshimura A, Nakao K.
    Circ Res; 2001 Apr 13; 88(7):727-32. PubMed ID: 11304496
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C, Susini C, Melmed S.
    J Clin Invest; 1999 Nov 13; 104(9):1277-85. PubMed ID: 10545526
    [Abstract] [Full Text] [Related]

  • 10. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.
    Nicholson SE, Willson TA, Farley A, Starr R, Zhang JG, Baca M, Alexander WS, Metcalf D, Hilton DJ, Nicola NA.
    EMBO J; 1999 Jan 15; 18(2):375-85. PubMed ID: 9889194
    [Abstract] [Full Text] [Related]

  • 11. Cytokine-inducible SH2 protein (CIS3) and JAK2 binding protein (JAB) abolish prolactin receptor-mediated STAT5 signaling.
    Helman D, Sandowski Y, Cohen Y, Matsumoto A, Yoshimura A, Merchav S, Gertler A.
    FEBS Lett; 1998 Dec 18; 441(2):287-91. PubMed ID: 9883901
    [Abstract] [Full Text] [Related]

  • 12. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation.
    Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, Hoshino T, Kubo M, Yamashita A, Okabe M, Takeda K, Akira S, Matsumoto S, Toyonaga A, Sata M, Yoshimura A.
    J Exp Med; 2001 Feb 19; 193(4):471-81. PubMed ID: 11181699
    [Abstract] [Full Text] [Related]

  • 13. A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box.
    Hanada T, Yoshida T, Kinjyo I, Minoguchi S, Yasukawa H, Kato S, Mimata H, Nomura Y, Seki Y, Kubo M, Yoshimura A.
    J Biol Chem; 2001 Nov 02; 276(44):40746-54. PubMed ID: 11522790
    [Abstract] [Full Text] [Related]

  • 14. LIF-induced STAT3 signaling in murine versus human embryonal carcinoma (EC) cells.
    Schuringa JJ, van der Schaaf S, Vellenga E, Eggen BJ, Kruijer W.
    Exp Cell Res; 2002 Mar 10; 274(1):119-29. PubMed ID: 11855863
    [Abstract] [Full Text] [Related]

  • 15. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.
    Minami M, Inoue M, Wei S, Takeda K, Matsumoto M, Kishimoto T, Akira S.
    Proc Natl Acad Sci U S A; 1996 Apr 30; 93(9):3963-6. PubMed ID: 8632998
    [Abstract] [Full Text] [Related]

  • 16. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
    Auernhammer CJ, Chesnokova V, Bousquet C, Melmed S.
    Mol Endocrinol; 1998 Jul 30; 12(7):954-61. PubMed ID: 9658400
    [Abstract] [Full Text] [Related]

  • 17. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
    Piekorz RP, Hocke GM.
    Cytokine; 1997 Sep 30; 9(9):639-49. PubMed ID: 9325012
    [Abstract] [Full Text] [Related]

  • 18. A new protein containing an SH2 domain that inhibits JAK kinases.
    Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A.
    Nature; 1997 Jun 26; 387(6636):921-4. PubMed ID: 9202126
    [Abstract] [Full Text] [Related]

  • 19. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
    Ding Y, Chen D, Tarcsafalvi A, Su R, Qin L, Bromberg JS.
    J Immunol; 2003 Feb 01; 170(3):1383-91. PubMed ID: 12538698
    [Abstract] [Full Text] [Related]

  • 20. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3.
    Minamoto S, Ikegame K, Ueno K, Narazaki M, Naka T, Yamamoto H, Matsumoto T, Saito H, Hosoe S, Kishimoto T.
    Biochem Biophys Res Commun; 1997 Aug 08; 237(1):79-83. PubMed ID: 9266833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.